We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

8 hedge funds and large institutions have $2.14M invested in Catheter Precision in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $1.82M → $2.14M (+$321K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

11% less funds holding

Funds holding: 9 → 8 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$796K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$239K
3
Two Sigma Investments
Two Sigma Investments
New York
+$239K
4
UBS Group
UBS Group
Switzerland
+$79.6K

Top Sellers

Rank Fund Capital Flow
1
Principal Financial Group
Principal Financial Group
Iowa
-$233K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$79.6K
3
Citadel Advisors
Citadel Advisors
Florida
-$10K
4
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$7K
5
Ameriprise
Ameriprise
Minnesota
-$6K

VTAK Hedge Fund Activity: Q3 2020 in Review

8 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q3 2020, worth a combined $2.14M — up 18% from $1.82M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of VTAK and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $796K. The largest seller was Principal Financial Group, exiting entirely with an estimated $233K sold.

  • 8 institutional investors held Catheter Precision (VTAK) as of Q3 2020, down from 9 in Q2 2020.
  • Funds reported $2.14M of Catheter Precision stock for Q3 2020, up 18% quarter-over-quarter.
  • 1 fund opened new Catheter Precision positions in Q3 2020 and 2 closed out, a net change of -1 holder.
  • The largest Catheter Precision buyer in Q3 2020 was Renaissance Technologies, an estimated $796K added.
  • The largest Catheter Precision seller in Q3 2020 was Principal Financial Group, an estimated $233K sold.

Based on aggregated 13F filings for Q3 2020.